Quarterly report pursuant to Section 13 or 15(d)

Note Receivable

Note Receivable
6 Months Ended
Jun. 30, 2021
Receivables [Abstract]  
Note Receivable

11. Note Receivable


On October 1, 2018, the Company completed the sale of its spine implant business to CTL Medical. The sale included a $6.0 million noninterest bearing note receivable payable over a 36 month term to mature on October 1, 2021. The note receivable included an imputed interest rate of 10%. As of June 30, 2021, the note has been paid in full and there will be no further cash proceeds from the note.